Stay updated on Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.

Latest updates to the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now includes a note that PubMed-pulled publications may not all pertain to the study, and the Revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThe government funding status notice was removed from the page, with no evident changes to trial details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedNo additions or deletions were observed on the page; the study details content remains unchanged.SummaryDifference0.1%

- Check47 days agoChange DetectedUpdated location data: removing several 2024-era addresses and adding new 2025 entries across multiple countries, notably including Amsterdam (North Holland) and various new international locations.SummaryDifference4%

- Check54 days agoChange DetectedUpdated publication metadata for the same article: the online-ahead-of-print note is removed and the citation date is adjusted to reflect the print/online status.SummaryDifference0.3%

- Check61 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

Stay in the know with updates to Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Placebo in Bladder Cancer Surgery Follow-up Clinical Trial page.